Clinical Chemistry, Malmö
951 – 960 of 1294
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
Role of CCP2 of the C4b-binding protein beta-chain in protein S binding evaluated by mutagenesis and monoclonal antibodies.
(
- Contribution to journal › Article
-
Mark
The regulation of factor Va activity by activated protein C -Importance of the individual activated protein C cleavage sites in factor Va
2003)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Expression and immunolocalisation of neutral endopeptidase in prostate cancer
(
- Contribution to journal › Article
-
Mark
Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies
(
- Contribution to journal › Article
-
Mark
Stabilyte (TM) tubes that contain strongly acidic citrate prevent in vitro complex formation between activated protein C and protein C inhibitor
(
- Contribution to journal › Letter
-
Mark
Prostate specific antigen based biennial screening is sufficient to detect almost all prostate cancers while still curable
(
- Contribution to journal › Article
-
Mark
Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer.
(
- Contribution to journal › Article
-
Mark
Factor V Leiden in pregnancies complicated by placental abruption
(
- Contribution to journal › Article
-
Mark
Probing plasma clearance of the thrombin-antithrombin complex with a monoclonal antibody against the putative serpin-enzyme complex receptor-binding site.
(
- Contribution to journal › Article
-
Mark
Structural and functional studies of factor V in health and disease
2003)(
- Thesis › Doctoral thesis (compilation)